In a blind race to cure HIV, can Gene therapy be a deal-breaker?
Jan 20, 2020
HIV infection has become a global health burden, has claimed over 32 million lives so far since the very first case of AIDS was reported in 1981. According to a report put ...
Read More
Malignant Pleural Mesothelioma Upcoming Therapies
Jan 15, 2020
Malignant pleural mesothelioma treatment market includes several immunotherapy agents, in the pipeline including Keytruda, Opdivo and Yervoy, which have shown promising ant...
Read More
Malignant pleural mesothelioma market: Elusive treatment approaches and Poor diagnosis
Jan 13, 2020
Malignant pleural mesothelioma (MPM) is a malignancy of pleural layers within the lung cavity and inner sides of the ribs. Year of research has revealed asbestos expo...
Read More
Anaphylaxis: A Rare Disease
Jan 10, 2020
Anaphylaxis is a rare disease which can even result in life-threatening situations. Mostly the allergic reaction is due to food, insect stings, medications and latex. ...
Read More
Egg Allergy Market: Second most common food allergy but no approved therapy
Jan 6, 2020
Hen’s egg allergy is the second most common type of allergy after cow’s milk. In infants and young children, Egg poses as one of the most vital allergens degrading the ...
Read More
Chronic Hand Eczema Market Analysis and Forecast
Eczema is an umbrella term comprising skin disorders characterised by dry, discoloured, itchy and inflamed skin. Hand eczema (HE) are non-infectious, inflammatory cutaneous...
Read More
Angelman syndrome: A Rare Genetic Disorder
Jan 1, 2020
Angelman syndrome is a rare genetic disorder, which affects the nervous system. The people who are affected by the disease, show the characteristics like intellectual disab...
Read More
Atopic dermatitis market: Increasing prevalence and topical treatments
Dec 30, 2019
Atopic dermatitis, also known as atopic eczema, is a condition that results in itchy, scaly and red skin. It is an inflammatory skin disease which is a common recurrent for...
Read More
Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval
Dec 17, 2019
Wave Life Sciences has recently announced the discontinuation of its drug suvodirsen, for the treatment of a rare Duchenne Muscular Dystrophy mutation. Duchenne Muscu...
Read More
Increasing cases of Mania and Bipolar disorder market
Dec 16, 2019
Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American P...
Read More
Fragile X Syndrome Market
Dec 13, 2019
AI-driven treatment approach and growing Fragile X Syndrome market size Healx Pharma has recently partnered with Boehringer Ingelheim to advance the treatment market and in...
Read More
Acquisition of ArQule; Synthorx; and Zentalis nabs a raise
Dec 10, 2019
Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay USD 20 for each share in cash for ...
Read More
Are Rare Diseases truly Rare?
Dec 9, 2019
Rare diseases, as the name depicts, affect only a small number of people compared to the other disease. Worldwide, one out of 15 persons could be affected by a rare disease...
Read More
Cumberland’s methotrexate product gets approval in the US; Baker Brothers purchases stake in Kodiak’s KSI-301; Sanofi offloads Seprafilm unit to Baxter
Dec 3, 2019
Cumberland Pharmaceuticals has recently received approval from the US FDA for its RediTrex injection for the treatment of rheumatoid arthritis. Cumberland pharmaceuticals p...
Read More
Chronic Refractory Cough Market landscape: A new approach to treating cough
Dec 2, 2019
When cough seems everlasting, mortifying, and excruciating, it is high time to consult a physician as you might be stricken by chronic cough, which can be irritating and ma...
Read More
